Paid Clinical Trials Annapolis

Discover 1,745 paid clinical trials in Annapolis, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,745

PF-07220060 with LetrozoleStudy of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease

Recruiting

PHASE3

Sponsor:

Pfizer

Location:

Annapolis MD, Baltimore MD, Washington DC, Savannah GAshow 23 more

Code:

NCT06760637

Conditions

Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

PF-07220060

letrozole

abemaciclib

palbociclib

ribociclib

GleolanGleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)

Recruiting

PHASE3

Sponsor:

NX Development Corp

Location:

Annapolis MD

Code:

NCT05804370

Conditions

Ovarian Cancer

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Gleolan

TORL-1-23CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

Recruiting

PHASE2

Sponsor:

TORL Biotherapeutics, LLC

Location:

Annapolis MD, Doylestown PA, Norfolk VA, Torontoshow 9 more

Code:

NCT06690775

Conditions

Epithelial Ovarian Cancer

Primary Peritoneal

Fallopian Tube Cancer

Endometrioid Ovarian Cancer

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

TORL-1-23

Pegfilgrastim (drug)

ZN-c3A Study of ZN-c3 in Women With Recurrent or Persistent Uterine Serous Carcinoma

Recruiting

PHASE2

Sponsor:

K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc

Location:

Annapolis MD, Baltimore MD, Warrenton VA, Philadelphia PAshow 32 more

Code:

NCT04814108

Conditions

Uterine Serous Carcinoma

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ZN-c3

SR vs. SAbRJoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer

Recruiting

PHASE3

Sponsor:

University of Texas Southwestern Medical Center

Location:

Annapolis MD, Baltimore MD, Falls Church VA, Philadelphia PAshow 38 more

Code:

NCT02468024

Conditions

Non-Small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Lung Surgery

Radiation therapy

Mino-Lok TherapyMino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI

Recruiting

PHASE3

Sponsor:

Leonard-Meron Biosciences, Inc.

Location:

Annapolis MD, Washington DC, Newark NJ, Salem VAshow 15 more

Code:

NCT02901717

Conditions

Catheter-related Infections

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Mino-Lok

Antibiotic lock

Shoulder StabilizationOpen Versus Arthroscopic Stabilization of Shoulder Instability with Subcritical Bone Loss: the OASIS Trial

Recruiting

Sponsor:

University of Pittsburgh

Location:

Annapolis MD, Bethesda MD, Charlottesville VA, Pittsburgh PAshow 13 more

Code:

NCT04809064

Conditions

Shoulder Dislocation

Glenohumeral Dislocation

Anterior Shoulder Dislocation

Eligibility Criteria

Sex: All

Age: 17 - 50

Healthy Volunteers: Not accepted

Interventions

Arthroscopic Bankart repair procedure

Open Bankart

Latarjet

Post-Operative Rehabilitation

GLSI-100Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

Recruiting

PHASE3

Sponsor:

Greenwich LifeSciences, Inc.

Location:

Annapolis MD, Washington DC, Fairfax VA, Philadelphia PAshow 32 more

Code:

NCT05232916

Conditions

Breast Cancer

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Placebo

GLSI-100

Talquetamab, Pomalidomide, Teclistamab, Elotuzumab, Dexamethasone, BortezomibA Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide

Recruiting

PHASE3

Sponsor:

Janssen Research & Development, LLC

Location:

Annapolis MD, Baltimore MD, Hershey PA, Philadelphia PAshow 33 more

Code:

NCT06208150

Conditions

Relapsed or Refractory Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Talquetamab

Pomalidomide

Teclistamab

Elotuzumab

Dexamethasone

LutonixPost Approval Study Investigating Lutonix Drug Coated Balloon for Treatment of Dysfunctional Arteriovenous Fistulae

Recruiting

Sponsor:

C. R. Bard

Location:

Annapolis MD, Hershey PA, Norfolk VA, New York NYshow 20 more

Code:

NCT03506308

Conditions

Arteriovenous Fistula

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

LUTONIX 035 Drug Coated Balloon PTA Catheter